InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (12 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
12
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Rubinstein Julie, Chief Operating Officer. Officer active across 1 company, notably Adaptive Biotechnologies Corp. In total, 40 reports have been logged. Breakdown: 0 buy · 12 sells. Total volume traded: €4.2m. History available since 4 March 2022. The latest transaction was disclosed on 27 April 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Rubinstein Julie
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations40 total
14,707 shares@ US$8.460.0036% mcap1.2% of flowCommon StockSEC:0001780664-26-000032:0
19,037 shares@ US$14.230.0078% mcap2.6% of flowCommon StockSEC:0001780664-26-000032:1
14,722 shares@ US$8.460.0052% mcap2.1% of flowCommon StockSEC:0001780664-26-000030:0
14,722 shares@ US$8.460.0051% mcap2.1% of flowCommon StockSEC:0001780664-26-000028:0
19,060 shares@ US$14.570.011% mcap2.8% of flowCommon StockSEC:0001780664-26-000028:1
14,722 shares@ US$8.460.0048% mcap1.2% of flowCommon StockSEC:0001780664-26-000028:2
19,060 shares@ US$14.550.011% mcap2.8% of flowCommon StockSEC:0001780664-26-000028:3
14,722 shares@ US$8.460.0048% mcap1.2% of flowCommon StockSEC:0001780664-26-000028:4
11,881 shares@ US$12.140.0055% mcap1.4% of flowCommon StockSEC:0001780664-26-000028:5
30,941 shares@ US$14.660.017% mcap4.5% of flowCommon StockSEC:0001780664-26-000028:6
14,722 shares@ US$8.460.0051% mcap2.1% of flowCommon StockSEC:0001780664-26-000026:0
14,722 shares@ US$7.270.0045% mcap1.8% of flowCommon StockSEC:0001780664-26-000024:0
14,722 shares@ US$7.270.0045% mcap1.9% of flowCommon StockSEC:0001780664-26-000022:0
14,722 shares@ US$7.270.0045% mcap1.8% of flowCommon StockSEC:0001780664-26-000020:0
14,722 shares@ US$7.270.0045% mcap1.9% of flowCommon StockSEC:0001780664-26-000018:0
2,738 shares@ US$12.490.0013% mcap0.3% of flowCommon StockSEC:0001780664-26-000018:1
16,322 shares@ US$13.480.0086% mcap2.2% of flowCommon StockSEC:0001780664-26-000018:2
14,722 shares@ US$7.270.0042% mcap1.1% of flowCommon StockSEC:0001780664-26-000018:3
19,060 shares@ US$12.630.0095% mcap2.5% of flowCommon StockSEC:0001780664-26-000018:4
14,722 shares@ US$7.270.0042% mcap1.1% of flowCommon StockSEC:0001780664-26-000018:5
19,060 shares@ US$13.450.0100% mcap2.6% of flowCommon StockSEC:0001780664-26-000018:6
14,722 shares@ US$7.270.0045% mcap1.8% of flowCommon StockSEC:0001780664-26-000016:0
14,722 shares@ US$6.550.0041% mcap1.7% of flowCommon StockSEC:0001780664-26-000014:0
14,722 shares@ US$6.550.0041% mcap1.7% of flowCommon StockSEC:0001780664-26-000012:0
122,523 shares@ US$13.170.068% mcap27.8% of flowCommon StockSEC:0001780664-26-000008:0
25 of 40 declarations
About Rubinstein Julie
RUBINSTEIN JULIE is Directeur des Opérations at Adaptive Biotechnologies Corp (XNAS), where she is listed as President and COO. She has 40 filings in total, and in the sampled recent filings between 2022-03-08 and 2026-04-29, the transactions are entirely sells for EUR 4176540, with the modal transaction nature listed as Levée d'options.
